ARCHIVES

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

This article is from The Cancer Letter archive.

Vol. 36 No. 14 | April 16, 2010

Download PDF Visit The Full Archive

Related Articles

Reagan Goes On Record Against Smoking, Dietary Fat

April 22, 1988

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

New Coalition To Lobby for Prevention

November 24, 1978

Reorganization Answer Now Coming In – Viroloy Extramural Research To Be Under Carcinogenesis

March 24, 1978